UBS Group’s C5 Acquisition Corporation CXAC Stock Holding History

UBS Group’s Portfolio CXAC Stock Details CXAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-100	Closed	-$1.1K	–	10505
2023 Q3	$1.1K	Buy	+100	New	+$1.08K	﹤0.01%	8105
2023 Q2	–	Sell	-384	Closed	-$4.01K	–	10134
2023 Q1	$4.01K	Sell	384 -765	-67%	-$7.91K	﹤0.01%	8244
2022 Q4	$11.7K	Buy	1,149 +350	+44%	+$3.54K	﹤0.01%	8368
2022 Q3	$8K	Buy	+799	New	+$8K	﹤0.01%	8790

UBS Group's CXAC Position: Q4 2023 in Review

UBS Group sold out of C5 Acquisition Corporation (CXAC) in Q4 2023, closing a stake of 100 shares — an estimated $1.1K sold.

UBS Group first reported a position in CXAC in Q3 2022 and held it in 4 quarters. The position peaked at $11.7K in Q4 2022. 0 funds tracked by Wall St. Rank hold CXAC as of Q4 2023.

UBS Group reported no remaining C5 Acquisition Corporation position as of Q4 2023 after selling out during the quarter.
UBS Group sold 100 C5 Acquisition Corporation shares in Q4 2023, an estimated $1.1K.
UBS Group first reported a position in C5 Acquisition Corporation in Q3 2022 and held it in 4 quarters.
UBS Group's C5 Acquisition Corporation position peaked at $11.7K in Q4 2022.
0 funds tracked by Wall St. Rank held C5 Acquisition Corporation as of Q4 2023.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.